Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
PLAGL1
|
ENSG00000118495.14 | PLAG1 like zinc finger 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PLAGL1 | hg19_v2_chr6_-_144385698_144385742 | -0.18 | 4.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_123691047 | 2.75 |
ENST00000373887.3
|
TRAF1
|
TNF receptor-associated factor 1 |
chr9_-_123691439 | 2.60 |
ENST00000540010.1
|
TRAF1
|
TNF receptor-associated factor 1 |
chr1_+_33207381 | 2.22 |
ENST00000401073.2
|
KIAA1522
|
KIAA1522 |
chr19_+_676385 | 2.19 |
ENST00000166139.4
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein) |
chr10_+_104155450 | 1.92 |
ENST00000471698.1
ENST00000189444.6 |
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
chr6_-_29595779 | 1.85 |
ENST00000355973.3
ENST00000377012.4 |
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr4_+_156588350 | 1.83 |
ENST00000296518.7
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr15_-_64338521 | 1.67 |
ENST00000457488.1
ENST00000558069.1 |
DAPK2
|
death-associated protein kinase 2 |
chr7_+_6144514 | 1.67 |
ENST00000306177.5
ENST00000465073.2 |
USP42
|
ubiquitin specific peptidase 42 |
chr17_-_61777090 | 1.59 |
ENST00000578061.1
|
LIMD2
|
LIM domain containing 2 |
chr21_+_45161301 | 1.54 |
ENST00000467908.1
|
PDXK
|
pyridoxal (pyridoxine, vitamin B6) kinase |
chr19_-_18653781 | 1.51 |
ENST00000596558.2
ENST00000453489.2 |
FKBP8
|
FK506 binding protein 8, 38kDa |
chr12_-_57522813 | 1.49 |
ENST00000556155.1
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
chr17_-_3595181 | 1.47 |
ENST00000552050.1
|
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
chr20_+_55966444 | 1.43 |
ENST00000356208.5
ENST00000440234.2 |
RBM38
|
RNA binding motif protein 38 |
chr4_+_74735102 | 1.40 |
ENST00000395761.3
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
chr19_-_1592652 | 1.40 |
ENST00000156825.1
ENST00000434436.3 |
MBD3
|
methyl-CpG binding domain protein 3 |
chr9_-_95896550 | 1.37 |
ENST00000375446.4
|
NINJ1
|
ninjurin 1 |
chrX_+_9433048 | 1.36 |
ENST00000217964.7
|
TBL1X
|
transducin (beta)-like 1X-linked |
chr5_-_150460914 | 1.32 |
ENST00000389378.2
|
TNIP1
|
TNFAIP3 interacting protein 1 |
chr19_-_3028354 | 1.29 |
ENST00000586422.1
|
TLE2
|
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
chr1_-_95007193 | 1.28 |
ENST00000370207.4
ENST00000334047.7 |
F3
|
coagulation factor III (thromboplastin, tissue factor) |
chr16_-_11680759 | 1.25 |
ENST00000571459.1
ENST00000570798.1 ENST00000572255.1 ENST00000574763.1 ENST00000574703.1 ENST00000571277.1 ENST00000381810.3 |
LITAF
|
lipopolysaccharide-induced TNF factor |
chr21_+_43639211 | 1.24 |
ENST00000450121.1
ENST00000398449.3 ENST00000361802.2 |
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1 |
chr16_-_4664860 | 1.22 |
ENST00000587615.1
ENST00000587649.1 ENST00000590965.1 ENST00000591401.1 ENST00000283474.7 |
UBALD1
|
UBA-like domain containing 1 |
chr11_-_64512469 | 1.20 |
ENST00000377485.1
|
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr19_-_1592828 | 1.19 |
ENST00000592012.1
|
MBD3
|
methyl-CpG binding domain protein 3 |
chr9_+_116917807 | 1.17 |
ENST00000356083.3
|
COL27A1
|
collagen, type XXVII, alpha 1 |
chr9_-_136857403 | 1.15 |
ENST00000406606.3
ENST00000371850.3 |
VAV2
|
vav 2 guanine nucleotide exchange factor |
chr3_+_53195136 | 1.15 |
ENST00000394729.2
ENST00000330452.3 |
PRKCD
|
protein kinase C, delta |
chr4_+_4861385 | 1.13 |
ENST00000382723.4
|
MSX1
|
msh homeobox 1 |
chr19_+_45251804 | 1.13 |
ENST00000164227.5
|
BCL3
|
B-cell CLL/lymphoma 3 |
chr5_+_179247759 | 1.13 |
ENST00000389805.4
ENST00000504627.1 ENST00000402874.3 ENST00000510187.1 |
SQSTM1
|
sequestosome 1 |
chr6_+_138188551 | 1.12 |
ENST00000237289.4
ENST00000433680.1 |
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr1_-_935361 | 1.12 |
ENST00000484667.2
|
HES4
|
hes family bHLH transcription factor 4 |
chr12_-_6451186 | 1.12 |
ENST00000540022.1
ENST00000536194.1 |
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A |
chr19_+_7600584 | 1.11 |
ENST00000600737.1
|
PNPLA6
|
patatin-like phospholipase domain containing 6 |
chr5_-_1112141 | 1.11 |
ENST00000264930.5
|
SLC12A7
|
solute carrier family 12 (potassium/chloride transporter), member 7 |
chr17_+_78075361 | 1.11 |
ENST00000577106.1
ENST00000390015.3 |
GAA
|
glucosidase, alpha; acid |
chr19_+_13261216 | 1.09 |
ENST00000587885.1
ENST00000292433.3 |
IER2
|
immediate early response 2 |
chr17_+_36861735 | 1.08 |
ENST00000378137.5
ENST00000325718.7 |
MLLT6
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 |
chr2_+_85360499 | 1.07 |
ENST00000282111.3
|
TCF7L1
|
transcription factor 7-like 1 (T-cell specific, HMG-box) |
chr19_+_12902289 | 1.06 |
ENST00000302754.4
|
JUNB
|
jun B proto-oncogene |
chr1_-_935491 | 1.06 |
ENST00000304952.6
|
HES4
|
hes family bHLH transcription factor 4 |
chr10_-_105615164 | 1.04 |
ENST00000355946.2
ENST00000369774.4 |
SH3PXD2A
|
SH3 and PX domains 2A |
chr20_+_61904137 | 1.04 |
ENST00000370283.4
ENST00000523114.1 ENST00000547204.1 ENST00000549047.1 ENST00000523460.1 ENST00000519604.1 ENST00000519273.2 ENST00000370275.4 |
ARFGAP1
|
ADP-ribosylation factor GTPase activating protein 1 |
chr9_-_136344197 | 1.03 |
ENST00000414172.1
ENST00000371897.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr7_-_139876812 | 1.03 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
chr19_+_10381769 | 1.02 |
ENST00000423829.2
ENST00000588645.1 |
ICAM1
|
intercellular adhesion molecule 1 |
chr16_+_29817841 | 1.02 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr22_-_19137796 | 1.01 |
ENST00000086933.2
|
GSC2
|
goosecoid homeobox 2 |
chr1_-_38273840 | 1.00 |
ENST00000373044.2
|
YRDC
|
yrdC N(6)-threonylcarbamoyltransferase domain containing |
chr19_-_48048518 | 1.00 |
ENST00000595558.1
ENST00000263351.5 |
ZNF541
|
zinc finger protein 541 |
chr10_-_6019552 | 1.00 |
ENST00000379977.3
ENST00000397251.3 ENST00000397248.2 |
IL15RA
|
interleukin 15 receptor, alpha |
chr4_-_74964904 | 0.99 |
ENST00000508487.2
|
CXCL2
|
chemokine (C-X-C motif) ligand 2 |
chr11_+_2421718 | 0.99 |
ENST00000380996.5
ENST00000333256.6 ENST00000380992.1 ENST00000437110.1 ENST00000435795.1 |
TSSC4
|
tumor suppressing subtransferable candidate 4 |
chr3_-_129035120 | 0.97 |
ENST00000333762.4
|
H1FX
|
H1 histone family, member X |
chr1_-_205290865 | 0.97 |
ENST00000367157.3
|
NUAK2
|
NUAK family, SNF1-like kinase, 2 |
chr6_-_32821599 | 0.97 |
ENST00000354258.4
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr16_-_11681023 | 0.96 |
ENST00000570904.1
ENST00000574701.1 |
LITAF
|
lipopolysaccharide-induced TNF factor |
chr11_+_66886717 | 0.96 |
ENST00000398645.2
|
KDM2A
|
lysine (K)-specific demethylase 2A |
chr14_+_24779376 | 0.94 |
ENST00000530080.1
|
LTB4R2
|
leukotriene B4 receptor 2 |
chr4_+_156588249 | 0.93 |
ENST00000393832.3
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr11_-_3186494 | 0.93 |
ENST00000389989.3
ENST00000542243.1 |
OSBPL5
|
oxysterol binding protein-like 5 |
chr17_+_78075498 | 0.93 |
ENST00000302262.3
|
GAA
|
glucosidase, alpha; acid |
chr16_+_57406368 | 0.92 |
ENST00000006053.6
ENST00000563383.1 |
CX3CL1
|
chemokine (C-X3-C motif) ligand 1 |
chr16_+_67562702 | 0.92 |
ENST00000379312.3
ENST00000042381.4 ENST00000540839.3 |
FAM65A
|
family with sequence similarity 65, member A |
chr21_+_26934165 | 0.92 |
ENST00000456917.1
|
MIR155HG
|
MIR155 host gene (non-protein coding) |
chr4_-_74904398 | 0.92 |
ENST00000296026.4
|
CXCL3
|
chemokine (C-X-C motif) ligand 3 |
chr17_+_40913264 | 0.91 |
ENST00000587142.1
ENST00000588576.1 |
RAMP2
|
receptor (G protein-coupled) activity modifying protein 2 |
chr14_-_21566731 | 0.91 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
chr16_-_11680791 | 0.91 |
ENST00000571976.1
ENST00000413364.2 |
LITAF
|
lipopolysaccharide-induced TNF factor |
chr19_+_2236509 | 0.90 |
ENST00000221494.5
|
SF3A2
|
splicing factor 3a, subunit 2, 66kDa |
chr11_-_72353451 | 0.90 |
ENST00000376450.3
|
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated |
chr6_+_31865552 | 0.90 |
ENST00000469372.1
ENST00000497706.1 |
C2
|
complement component 2 |
chr11_-_45687128 | 0.90 |
ENST00000308064.2
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
chr17_+_7788104 | 0.89 |
ENST00000380358.4
|
CHD3
|
chromodomain helicase DNA binding protein 3 |
chr22_+_22385332 | 0.88 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr19_-_5784610 | 0.88 |
ENST00000390672.2
ENST00000419421.2 |
PRR22
|
proline rich 22 |
chr1_-_32801825 | 0.87 |
ENST00000329421.7
|
MARCKSL1
|
MARCKS-like 1 |
chr1_+_16010779 | 0.87 |
ENST00000375799.3
ENST00000375793.2 |
PLEKHM2
|
pleckstrin homology domain containing, family M (with RUN domain) member 2 |
chr19_-_14201507 | 0.87 |
ENST00000533683.2
|
SAMD1
|
sterile alpha motif domain containing 1 |
chr16_+_29817399 | 0.86 |
ENST00000545521.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr3_-_39195037 | 0.85 |
ENST00000273153.5
|
CSRNP1
|
cysteine-serine-rich nuclear protein 1 |
chr2_+_102972363 | 0.84 |
ENST00000409599.1
|
IL18R1
|
interleukin 18 receptor 1 |
chr10_-_6019455 | 0.84 |
ENST00000530685.1
ENST00000397255.3 ENST00000379971.1 ENST00000528354.1 ENST00000397250.2 ENST00000429135.2 |
IL15RA
|
interleukin 15 receptor, alpha |
chr19_+_10982189 | 0.84 |
ENST00000327064.4
ENST00000588947.1 |
CARM1
|
coactivator-associated arginine methyltransferase 1 |
chr21_-_45660840 | 0.83 |
ENST00000400377.3
|
ICOSLG
|
inducible T-cell co-stimulator ligand |
chr9_-_38069208 | 0.83 |
ENST00000377707.3
ENST00000377700.4 |
SHB
|
Src homology 2 domain containing adaptor protein B |
chr16_+_66638685 | 0.83 |
ENST00000565003.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
chr16_-_11681316 | 0.83 |
ENST00000571688.1
|
LITAF
|
lipopolysaccharide-induced TNF factor |
chr19_-_19006890 | 0.83 |
ENST00000247005.6
|
GDF1
|
growth differentiation factor 1 |
chr5_-_150460539 | 0.82 |
ENST00000520931.1
ENST00000520695.1 ENST00000521591.1 ENST00000518977.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
chr10_-_104001231 | 0.82 |
ENST00000370002.3
|
PITX3
|
paired-like homeodomain 3 |
chr13_+_110959598 | 0.81 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr6_-_160114293 | 0.81 |
ENST00000337404.4
ENST00000538183.2 |
SOD2
|
superoxide dismutase 2, mitochondrial |
chr8_+_145149930 | 0.81 |
ENST00000318911.4
|
CYC1
|
cytochrome c-1 |
chr9_-_132404374 | 0.80 |
ENST00000277459.4
ENST00000450050.2 ENST00000277458.4 |
ASB6
|
ankyrin repeat and SOCS box containing 6 |
chr11_+_369804 | 0.80 |
ENST00000329962.6
|
B4GALNT4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
chr17_+_27895609 | 0.80 |
ENST00000581411.2
ENST00000301057.7 |
TP53I13
|
tumor protein p53 inducible protein 13 |
chr9_-_136344237 | 0.80 |
ENST00000432868.1
ENST00000371899.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr21_-_18985230 | 0.80 |
ENST00000457956.1
ENST00000348354.6 |
BTG3
|
BTG family, member 3 |
chr8_+_145203548 | 0.78 |
ENST00000534366.1
|
MROH1
|
maestro heat-like repeat family member 1 |
chr11_+_64001962 | 0.78 |
ENST00000309422.2
|
VEGFB
|
vascular endothelial growth factor B |
chr17_-_42200996 | 0.78 |
ENST00000587135.1
ENST00000225983.6 ENST00000393622.2 ENST00000588703.1 |
HDAC5
|
histone deacetylase 5 |
chr4_+_74702214 | 0.78 |
ENST00000226317.5
ENST00000515050.1 |
CXCL6
|
chemokine (C-X-C motif) ligand 6 |
chr17_+_77751931 | 0.78 |
ENST00000310942.4
ENST00000269399.5 |
CBX2
|
chromobox homolog 2 |
chr17_-_61777459 | 0.78 |
ENST00000578993.1
ENST00000583211.1 ENST00000259006.3 |
LIMD2
|
LIM domain containing 2 |
chr9_-_132805430 | 0.77 |
ENST00000446176.2
ENST00000355681.3 ENST00000420781.1 |
FNBP1
|
formin binding protein 1 |
chr19_+_45504688 | 0.77 |
ENST00000221452.8
ENST00000540120.1 ENST00000505236.1 |
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B |
chr10_+_75670862 | 0.76 |
ENST00000446342.1
ENST00000372764.3 ENST00000372762.4 |
PLAU
|
plasminogen activator, urokinase |
chr8_+_145133493 | 0.76 |
ENST00000316052.5
ENST00000525936.1 |
EXOSC4
|
exosome component 4 |
chr1_-_184943610 | 0.75 |
ENST00000367511.3
|
FAM129A
|
family with sequence similarity 129, member A |
chr9_-_136214877 | 0.75 |
ENST00000446777.1
ENST00000343730.5 ENST00000344469.5 ENST00000371999.1 ENST00000494177.2 ENST00000457204.2 |
MED22
|
mediator complex subunit 22 |
chr15_-_77712477 | 0.75 |
ENST00000560626.2
|
PEAK1
|
pseudopodium-enriched atypical kinase 1 |
chr16_-_11485922 | 0.73 |
ENST00000599216.1
|
CTD-3088G3.8
|
Protein LOC388210 |
chrX_-_153285395 | 0.72 |
ENST00000369980.3
|
IRAK1
|
interleukin-1 receptor-associated kinase 1 |
chr6_+_14117872 | 0.72 |
ENST00000379153.3
|
CD83
|
CD83 molecule |
chr8_-_145582118 | 0.72 |
ENST00000455319.2
ENST00000331890.5 |
FBXL6
|
F-box and leucine-rich repeat protein 6 |
chr3_+_126243126 | 0.72 |
ENST00000319340.2
|
CHST13
|
carbohydrate (chondroitin 4) sulfotransferase 13 |
chr15_+_74908147 | 0.72 |
ENST00000568139.1
ENST00000563297.1 ENST00000568488.1 ENST00000352989.5 ENST00000348245.3 |
CLK3
|
CDC-like kinase 3 |
chr6_-_4079334 | 0.72 |
ENST00000492651.1
ENST00000498677.1 ENST00000274673.3 |
FAM217A
|
family with sequence similarity 217, member A |
chr17_-_40829026 | 0.72 |
ENST00000412503.1
|
PLEKHH3
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3 |
chr15_+_74287118 | 0.71 |
ENST00000563500.1
|
PML
|
promyelocytic leukemia |
chr19_+_45349432 | 0.71 |
ENST00000252485.4
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B) |
chr22_-_50968419 | 0.71 |
ENST00000425169.1
ENST00000395680.1 ENST00000395681.1 ENST00000395678.3 ENST00000252029.3 |
TYMP
|
thymidine phosphorylase |
chr17_+_59529743 | 0.71 |
ENST00000589003.1
ENST00000393853.4 |
TBX4
|
T-box 4 |
chr19_-_51017881 | 0.71 |
ENST00000601207.1
ENST00000598657.1 ENST00000376916.3 |
ASPDH
|
aspartate dehydrogenase domain containing |
chr2_+_234263120 | 0.70 |
ENST00000264057.2
ENST00000427930.1 |
DGKD
|
diacylglycerol kinase, delta 130kDa |
chrX_-_153285251 | 0.70 |
ENST00000444230.1
ENST00000393682.1 ENST00000393687.2 ENST00000429936.2 ENST00000369974.2 |
IRAK1
|
interleukin-1 receptor-associated kinase 1 |
chr2_-_175870085 | 0.70 |
ENST00000409156.3
|
CHN1
|
chimerin 1 |
chr11_+_43964055 | 0.70 |
ENST00000528572.1
|
C11orf96
|
chromosome 11 open reading frame 96 |
chr15_-_38856836 | 0.70 |
ENST00000450598.2
ENST00000559830.1 ENST00000558164.1 ENST00000310803.5 |
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
chr7_+_143078652 | 0.69 |
ENST00000354434.4
ENST00000449423.2 |
ZYX
|
zyxin |
chr11_+_73087309 | 0.69 |
ENST00000064780.2
ENST00000545687.1 |
RELT
|
RELT tumor necrosis factor receptor |
chr17_-_79623597 | 0.69 |
ENST00000574024.1
ENST00000331056.5 |
PDE6G
|
phosphodiesterase 6G, cGMP-specific, rod, gamma |
chr16_-_30905263 | 0.69 |
ENST00000572628.1
|
BCL7C
|
B-cell CLL/lymphoma 7C |
chr11_-_3186576 | 0.69 |
ENST00000348039.5
ENST00000263650.7 |
OSBPL5
|
oxysterol binding protein-like 5 |
chr16_-_66952779 | 0.69 |
ENST00000570262.1
ENST00000394055.3 ENST00000299752.4 |
CDH16
|
cadherin 16, KSP-cadherin |
chr11_-_3663212 | 0.68 |
ENST00000397067.3
|
ART5
|
ADP-ribosyltransferase 5 |
chr1_-_156721502 | 0.68 |
ENST00000357325.5
|
HDGF
|
hepatoma-derived growth factor |
chr2_+_97203082 | 0.68 |
ENST00000454558.2
|
ARID5A
|
AT rich interactive domain 5A (MRF1-like) |
chr16_+_1203194 | 0.68 |
ENST00000348261.5
ENST00000358590.4 |
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
chr1_+_1567474 | 0.68 |
ENST00000356026.5
|
MMP23B
|
matrix metallopeptidase 23B |
chr16_-_11036300 | 0.68 |
ENST00000331808.4
|
DEXI
|
Dexi homolog (mouse) |
chr6_-_13711773 | 0.67 |
ENST00000011619.3
|
RANBP9
|
RAN binding protein 9 |
chr15_+_89182178 | 0.67 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr16_-_70472946 | 0.67 |
ENST00000342907.2
|
ST3GAL2
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
chr11_+_45825896 | 0.67 |
ENST00000314134.3
|
SLC35C1
|
solute carrier family 35 (GDP-fucose transporter), member C1 |
chr1_-_231004220 | 0.67 |
ENST00000366663.5
|
C1orf198
|
chromosome 1 open reading frame 198 |
chr22_-_21387127 | 0.67 |
ENST00000426145.1
|
SLC7A4
|
solute carrier family 7, member 4 |
chr6_+_69345166 | 0.67 |
ENST00000370598.1
|
BAI3
|
brain-specific angiogenesis inhibitor 3 |
chr11_+_576494 | 0.67 |
ENST00000533464.1
ENST00000413872.2 ENST00000416188.2 |
PHRF1
|
PHD and ring finger domains 1 |
chr15_+_89182156 | 0.67 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr3_-_50374869 | 0.66 |
ENST00000327761.3
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1 |
chr22_+_38302285 | 0.66 |
ENST00000215957.6
|
MICALL1
|
MICAL-like 1 |
chr19_-_46272462 | 0.66 |
ENST00000317578.6
|
SIX5
|
SIX homeobox 5 |
chr1_-_41131326 | 0.66 |
ENST00000372684.3
|
RIMS3
|
regulating synaptic membrane exocytosis 3 |
chr1_-_41328018 | 0.65 |
ENST00000372638.2
|
CITED4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
chr11_-_65381643 | 0.65 |
ENST00000309100.3
ENST00000529839.1 ENST00000526293.1 |
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11 |
chr20_+_60878005 | 0.65 |
ENST00000253003.2
|
ADRM1
|
adhesion regulating molecule 1 |
chr11_-_65325203 | 0.65 |
ENST00000526927.1
ENST00000536982.1 |
LTBP3
|
latent transforming growth factor beta binding protein 3 |
chr7_+_86273700 | 0.65 |
ENST00000546348.1
|
GRM3
|
glutamate receptor, metabotropic 3 |
chr22_-_21386838 | 0.65 |
ENST00000403586.1
ENST00000382932.2 |
SLC7A4
|
solute carrier family 7, member 4 |
chr19_-_46296011 | 0.65 |
ENST00000377735.3
ENST00000270223.6 |
DMWD
|
dystrophia myotonica, WD repeat containing |
chr16_-_66952742 | 0.65 |
ENST00000565235.2
ENST00000568632.1 ENST00000565796.1 |
CDH16
|
cadherin 16, KSP-cadherin |
chr15_-_55581954 | 0.65 |
ENST00000336787.1
|
RAB27A
|
RAB27A, member RAS oncogene family |
chr19_+_56152262 | 0.64 |
ENST00000325333.5
ENST00000590190.1 |
ZNF580
|
zinc finger protein 580 |
chr9_+_35829208 | 0.64 |
ENST00000439587.2
ENST00000377991.4 |
TMEM8B
|
transmembrane protein 8B |
chr5_+_179233376 | 0.64 |
ENST00000376929.3
ENST00000514093.1 |
SQSTM1
|
sequestosome 1 |
chr16_+_81478775 | 0.64 |
ENST00000537098.3
|
CMIP
|
c-Maf inducing protein |
chr17_-_6735035 | 0.64 |
ENST00000338694.2
|
TEKT1
|
tektin 1 |
chr6_-_143266297 | 0.64 |
ENST00000367603.2
|
HIVEP2
|
human immunodeficiency virus type I enhancer binding protein 2 |
chr18_-_77711625 | 0.64 |
ENST00000357575.4
ENST00000590381.1 ENST00000397778.2 |
PQLC1
|
PQ loop repeat containing 1 |
chr5_+_131593364 | 0.63 |
ENST00000253754.3
ENST00000379018.3 |
PDLIM4
|
PDZ and LIM domain 4 |
chr15_-_62457480 | 0.63 |
ENST00000380392.3
|
C2CD4B
|
C2 calcium-dependent domain containing 4B |
chr6_-_44233361 | 0.63 |
ENST00000275015.5
|
NFKBIE
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
chr19_+_797443 | 0.63 |
ENST00000394601.4
ENST00000589575.1 |
PTBP1
|
polypyrimidine tract binding protein 1 |
chr1_+_212782012 | 0.63 |
ENST00000341491.4
ENST00000366985.1 |
ATF3
|
activating transcription factor 3 |
chr6_-_160114260 | 0.63 |
ENST00000367054.2
ENST00000367055.4 ENST00000444946.2 ENST00000452684.2 |
SOD2
|
superoxide dismutase 2, mitochondrial |
chr1_+_15671580 | 0.63 |
ENST00000529606.1
ENST00000314740.8 |
FHAD1
|
forkhead-associated (FHA) phosphopeptide binding domain 1 |
chr3_-_127541679 | 0.63 |
ENST00000265052.5
|
MGLL
|
monoglyceride lipase |
chr17_+_73452695 | 0.62 |
ENST00000582186.1
ENST00000582455.1 ENST00000581252.1 ENST00000579208.1 |
KIAA0195
|
KIAA0195 |
chr4_+_156588806 | 0.62 |
ENST00000513574.1
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr22_+_20119320 | 0.62 |
ENST00000334554.7
ENST00000320602.7 ENST00000405930.3 |
ZDHHC8
|
zinc finger, DHHC-type containing 8 |
chr17_-_6735012 | 0.62 |
ENST00000535086.1
|
TEKT1
|
tektin 1 |
chr15_+_67430339 | 0.61 |
ENST00000439724.3
|
SMAD3
|
SMAD family member 3 |
chr19_+_3224700 | 0.61 |
ENST00000292672.2
ENST00000541430.2 |
CELF5
|
CUGBP, Elav-like family member 5 |
chr8_-_23540402 | 0.61 |
ENST00000523261.1
ENST00000380871.4 |
NKX3-1
|
NK3 homeobox 1 |
chr12_-_50101165 | 0.61 |
ENST00000352151.5
ENST00000335154.5 ENST00000293590.5 |
FMNL3
|
formin-like 3 |
chr15_+_45926919 | 0.61 |
ENST00000561735.1
ENST00000260324.7 |
SQRDL
|
sulfide quinone reductase-like (yeast) |
chr14_-_35873856 | 0.61 |
ENST00000553342.1
ENST00000216797.5 ENST00000557140.1 |
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
chr21_+_34775772 | 0.61 |
ENST00000405436.1
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1) |
chr14_-_92414055 | 0.60 |
ENST00000342058.4
|
FBLN5
|
fibulin 5 |
chr9_-_123639600 | 0.60 |
ENST00000373896.3
|
PHF19
|
PHD finger protein 19 |
chr15_+_89346699 | 0.60 |
ENST00000558207.1
|
ACAN
|
aggrecan |
chr1_+_1567546 | 0.60 |
ENST00000378675.3
|
MMP23B
|
matrix metallopeptidase 23B |
chr17_-_5095126 | 0.60 |
ENST00000576772.1
ENST00000575779.1 |
ZNF594
|
zinc finger protein 594 |
chr3_-_47517302 | 0.60 |
ENST00000441517.2
ENST00000545718.1 |
SCAP
|
SREBF chaperone |
chr8_+_17354587 | 0.59 |
ENST00000494857.1
ENST00000522656.1 |
SLC7A2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 3.7 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.7 | 3.0 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.6 | 3.9 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.6 | 1.2 | GO:0002537 | nitric oxide production involved in inflammatory response(GO:0002537) |
0.5 | 1.6 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.5 | 2.1 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.5 | 1.9 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.5 | 0.5 | GO:0071506 | response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) |
0.5 | 1.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.5 | 1.4 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.4 | 2.2 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.4 | 2.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.4 | 1.3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.4 | 1.8 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.4 | 1.1 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.4 | 1.1 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.4 | 1.1 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.3 | 1.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 1.0 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.3 | 1.0 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
0.3 | 1.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 1.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 1.3 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.3 | 0.9 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.3 | 0.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.3 | 0.9 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.3 | 1.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.3 | 1.5 | GO:0072209 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) |
0.3 | 1.2 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.3 | 0.9 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.3 | 1.8 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.3 | 0.9 | GO:0071810 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.3 | 1.2 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.3 | 1.4 | GO:0001315 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.3 | 1.1 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.3 | 2.2 | GO:0030578 | PML body organization(GO:0030578) |
0.3 | 0.8 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.3 | 0.3 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) negative regulation of neuromuscular junction development(GO:1904397) |
0.3 | 1.1 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.3 | 0.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.3 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.3 | 1.0 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.3 | 0.8 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.3 | 0.8 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.3 | 1.0 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.3 | 0.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.2 | 0.2 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.2 | 0.7 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.2 | 0.7 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.2 | 1.4 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
0.2 | 0.9 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.2 | 0.9 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.2 | 0.7 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.2 | 0.7 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.2 | 0.7 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.2 | 1.3 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.2 | 0.7 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.2 | 0.2 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.2 | 1.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 0.2 | GO:1900756 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.2 | 0.6 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.2 | 0.8 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.2 | 0.4 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 0.8 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.2 | 0.8 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.2 | 0.6 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.2 | 0.2 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
0.2 | 0.6 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.2 | 1.2 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.6 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.2 | 0.6 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.2 | 0.6 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.2 | 1.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 0.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 0.6 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.2 | 0.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 0.5 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.2 | 0.9 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.2 | 0.9 | GO:0015811 | L-cystine transport(GO:0015811) |
0.2 | 0.7 | GO:0003409 | optic cup structural organization(GO:0003409) |
0.2 | 0.9 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.2 | 0.5 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.2 | 0.5 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.2 | 0.3 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 1.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.2 | 0.9 | GO:0033590 | response to cobalamin(GO:0033590) |
0.2 | 0.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 0.5 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.2 | 0.5 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.2 | 0.8 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 0.7 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.2 | 0.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 0.5 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
0.2 | 0.6 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.2 | 1.0 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.2 | 1.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 1.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 1.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.2 | 0.5 | GO:0097187 | dentinogenesis(GO:0097187) |
0.2 | 0.5 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.2 | 0.5 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.2 | 0.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 1.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.2 | 0.5 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
0.2 | 0.5 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.2 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 1.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.2 | 0.5 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.2 | 1.4 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.2 | 0.5 | GO:1905033 | positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
0.2 | 0.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.9 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.1 | 1.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.1 | GO:1901205 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
0.1 | 0.1 | GO:0072554 | blood vessel lumenization(GO:0072554) |
0.1 | 0.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.4 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.1 | GO:0060775 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.1 | 0.7 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
0.1 | 0.4 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
0.1 | 1.7 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.9 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.4 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.1 | 1.3 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.8 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.4 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.4 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 1.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.6 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.1 | 1.0 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.1 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.1 | 0.1 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.3 | GO:0048371 | lateral mesodermal cell differentiation(GO:0048371) |
0.1 | 3.3 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.7 | GO:0072683 | T cell extravasation(GO:0072683) |
0.1 | 0.4 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.1 | 0.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.4 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.1 | 0.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.4 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 0.4 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.1 | 0.8 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.3 | GO:0090170 | MAPK import into nucleus(GO:0000189) regulation of Golgi inheritance(GO:0090170) |
0.1 | 0.5 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.1 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.1 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.1 | 0.5 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.1 | 0.5 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.1 | 0.4 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.1 | 0.4 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.1 | 0.4 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.4 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 1.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.4 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.1 | 1.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.9 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) |
0.1 | 1.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.1 | 1.5 | GO:0034650 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.1 | 0.8 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.1 | 0.4 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.1 | 0.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 1.0 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.1 | 1.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.4 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 0.4 | GO:1904800 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.1 | 0.2 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
0.1 | 0.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.5 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 3.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.1 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.1 | 0.4 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.6 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 0.5 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.1 | 1.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.1 | 0.6 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
0.1 | 0.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 1.2 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.1 | 0.6 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.1 | 0.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.4 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.7 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.7 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 0.6 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.6 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 1.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 3.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 0.2 | GO:0003192 | mitral valve formation(GO:0003192) |
0.1 | 0.4 | GO:0040010 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) regulation of small intestine smooth muscle contraction(GO:1904347) positive regulation of small intestine smooth muscle contraction(GO:1904349) gastric mucosal blood circulation(GO:1990768) small intestine smooth muscle contraction(GO:1990770) |
0.1 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.9 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.5 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.1 | 0.1 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.1 | 0.6 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 0.3 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 0.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.2 | GO:0072237 | metanephric proximal tubule development(GO:0072237) |
0.1 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.7 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.4 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.1 | 0.3 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.1 | 0.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 0.6 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.1 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.1 | 0.1 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.4 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
0.1 | 0.1 | GO:1902024 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
0.1 | 1.6 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
0.1 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.2 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.1 | 1.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.3 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.1 | 0.5 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.1 | 0.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.1 | 0.3 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 0.1 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
0.1 | 1.0 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.1 | 0.4 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.1 | 0.6 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.1 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
0.1 | 0.5 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.1 | 0.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.4 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.2 | GO:0044691 | tooth eruption(GO:0044691) |
0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.5 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.7 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.3 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.1 | 1.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.3 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.2 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
0.1 | 0.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.1 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.1 | 0.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.6 | GO:0030805 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.4 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.1 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.1 | 0.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.7 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.2 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.1 | 0.9 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 0.2 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.1 | 0.6 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.4 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.1 | 0.5 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 1.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.1 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.6 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.1 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.4 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.3 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 0.7 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.1 | GO:0051595 | response to methylglyoxal(GO:0051595) |
0.1 | 0.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.6 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.1 | 0.6 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.1 | 0.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 1.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.4 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 1.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.3 | GO:0060166 | olfactory pit development(GO:0060166) Harderian gland development(GO:0070384) |
0.1 | 0.1 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.1 | 0.3 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 0.6 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.8 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.1 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.4 | GO:1904199 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
0.1 | 0.5 | GO:0072312 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.1 | 0.3 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.1 | 0.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.1 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) |
0.1 | 0.4 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.1 | 0.2 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 0.2 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.1 | 0.9 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.4 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 0.7 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.2 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.1 | 0.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 1.7 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.3 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.1 | 1.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.3 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 0.2 | GO:1904637 | cellular response to ether(GO:0071362) response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.1 | 0.2 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.1 | 0.3 | GO:1904647 | response to rotenone(GO:1904647) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.5 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 0.1 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 0.2 | GO:0060066 | oviduct development(GO:0060066) |
0.1 | 0.4 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 1.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.4 | GO:1990834 | response to odorant(GO:1990834) |
0.1 | 0.3 | GO:0072302 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) negative regulation of metanephric glomerulus development(GO:0072299) regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
0.1 | 0.2 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.1 | 0.4 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.1 | 0.9 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.1 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.4 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.1 | 0.1 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.1 | 0.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.2 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.1 | 0.2 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.1 | 0.2 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.1 | 0.5 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.1 | 0.4 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.2 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
0.1 | 0.5 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.2 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.4 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 0.2 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.1 | 0.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 1.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.1 | 0.4 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.1 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.1 | 0.3 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.1 | 0.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.2 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.1 | 0.7 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 1.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.4 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 | 0.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 4.0 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.1 | 0.5 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.1 | 5.6 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.1 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
0.1 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.2 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.1 | 0.2 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.1 | 1.4 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
0.1 | 2.7 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.8 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 0.2 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |